How human protein ACE2 modulation could stop the entry of coronavirus

Early in the pandemic, most research, including our own, focused on designing drugs that could block the virus's spike protein. This was a logical first step, but as we've seen, the virus is a moving target. It was rapidly evolving, and new variants acquired resistance due to changes in the surface spike glycoprotein (S protein).